A dataset of 29 trials comparing three antiparkinsonian interventions with placebo (a star-shaped network) in patients with later Parkinson's disease. The analysed continuous outcome is the change from baseline of patient off-time reduction.
data(nma.stowe2011)A data frame with 29 rows of arm-based data and 11 columns (maximum number of 2 arms).
The interventions have been coded as follows: 1, placebo plus levodopa (PBO+LD); 2, dopamine agonist plus levodopa (DA+LD); 3, catechol-O-methyl transferase inhibitors plus levodopa (COMBI+LD); and 4, monoamine oxidase type B inhibitors plus levodopa (MAOBI+LD).